Anne Luebke

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. pmc Loss of prestin does not alter the development of auditory cortical dendritic spines
    L J Bogart
    Program in Neuroscience, Harvard University, Cambridge, MA 02138, USA
    Neural Plast 2011:305621. 2011
  2. pmc Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system
    Ruolan Han
    Department of Biomedical Genetics and University of Rochester Stem Cell and Regenerative Medicine Institute, University of Rochester Medical Center, Elmwood Avenue, Rochester, NY 14642, USA
    J Biol 7:12. 2008
  3. doi request reprint Adenoviral and AAV-mediated gene transfer to the inner ear: role of serotype, promoter, and viral load on in vivo and in vitro infection efficiencies
    Anne E Luebke
    Department of Neurobiology, University of Rochester Medical Center, Rochester, NY 14642, USA
    Adv Otorhinolaryngol 66:87-98. 2009

Research Grants

Collaborators

Detail Information

Publications3

  1. pmc Loss of prestin does not alter the development of auditory cortical dendritic spines
    L J Bogart
    Program in Neuroscience, Harvard University, Cambridge, MA 02138, USA
    Neural Plast 2011:305621. 2011
    ....
  2. pmc Systemic 5-fluorouracil treatment causes a syndrome of delayed myelin destruction in the central nervous system
    Ruolan Han
    Department of Biomedical Genetics and University of Rochester Stem Cell and Regenerative Medicine Institute, University of Rochester Medical Center, Elmwood Avenue, Rochester, NY 14642, USA
    J Biol 7:12. 2008
    ..Nor are there any animal models that could enable the study of this important problem...
  3. doi request reprint Adenoviral and AAV-mediated gene transfer to the inner ear: role of serotype, promoter, and viral load on in vivo and in vitro infection efficiencies
    Anne E Luebke
    Department of Neurobiology, University of Rochester Medical Center, Rochester, NY 14642, USA
    Adv Otorhinolaryngol 66:87-98. 2009
    ..Issues such as vector toxicity and load, viral serotype and backbone, and promoter specificity are discussed and contrasted for both in vivo vs. in vitro inner ear gene transfer...

Research Grants11

  1. MOLECULAR BIOLOGY OF COCHLEAR EFFERENT RECEPTORS
    Anne Luebke; Fiscal Year: 2006
    ..Information gained from these studies will provide direct assessment of the molecular mechanisms used by the CGRP efferent feedback pathway to enhance sound-evoked activity in the cochlear nerve. ..
  2. MOLECULAR BIOLOGY OF COCHLEAR EFFERENT RECEPTORS
    Anne Luebke; Fiscal Year: 2001
    ..Information gained from these studies will contribute to future drug therapies that target cholinergic receptors of the cochlear efferent system with the goal of diminishing noise-induced hearing loss in humans. ..
  3. MOLECULAR BIOLOGY OF COCHLEAR EFFERENT RECEPTORS
    Anne Luebke; Fiscal Year: 2007
    ..Information gained from these studies will provide direct assessment of the molecular mechanisms used by the CGRP efferent feedback pathway to enhance sound-evoked activity in the cochlear nerve. ..
  4. MOLECULAR BIOLOGY OF COCHLEAR EFFERENT RECEPTORS
    Anne Luebke; Fiscal Year: 2005
    ..Information gained from these studies will provide direct assessment of the molecular mechanisms used by the CGRP efferent feedback pathway to enhance sound-evoked activity in the cochlear nerve. ..
  5. MOLECULAR BIOLOGY OF COCHLEAR EFFERENT RECEPTORS
    Anne Luebke; Fiscal Year: 2004
    ..Information gained from these studies will provide direct assessment of the molecular mechanisms used by the CGRP efferent feedback pathway to enhance sound-evoked activity in the cochlear nerve. ..
  6. MOLECULAR BIOLOGY OF COCHLEAR EFFERENT RECEPTORS
    Anne Luebke; Fiscal Year: 2002
    ..Information gained from these studies will contribute to future drug therapies that target cholinergic receptors of the cochlear efferent system with the goal of diminishing noise-induced hearing loss in humans. ..
  7. MOLECULAR BIOLOGY OF COCHLEAR EFFERENT RECEPTORS
    Anne Luebke; Fiscal Year: 2003
    ..Information gained from these studies will contribute to future drug therapies that target cholinergic receptors of the cochlear efferent system with the goal of diminishing noise-induced hearing loss in humans. ..
  8. Gene Transfer to the Inner Ear
    Anne Luebke; Fiscal Year: 2003
    ..Information gained from these studies will aid development of theraupeutic strategies targeted at genes involved in deafness. ..
  9. MOLECULAR BIOLOGY OF COCHLEAR EFFERENT RECEPTORS
    Anne Luebke; Fiscal Year: 2002
    ..Information gained from these studies will contribute to future drug therapies that target cholinergic receptors of the cochlear efferent system with the goal of diminishing noise-induced hearing loss in humans. ..
  10. MOLECULAR BIOLOGY OF COCHLEAR EFFERENT RECEPTORS
    Anne Luebke; Fiscal Year: 2009
    ..Information gained from these studies will provide direct assessment of the molecular mechanisms used by the CGRP efferent feedback pathway to enhance sound-evoked activity in the cochlear nerve. ..